DE69010336D1 - Pharmazeutische zusammensetzung zum abnehmen. - Google Patents

Pharmazeutische zusammensetzung zum abnehmen.

Info

Publication number
DE69010336D1
DE69010336D1 DE69010336T DE69010336T DE69010336D1 DE 69010336 D1 DE69010336 D1 DE 69010336D1 DE 69010336 T DE69010336 T DE 69010336T DE 69010336 T DE69010336 T DE 69010336T DE 69010336 D1 DE69010336 D1 DE 69010336D1
Authority
DE
Germany
Prior art keywords
slimming
pharmaceutical composition
ephedrine
human
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69010336T
Other languages
English (en)
Other versions
DE69010336T2 (de
Inventor
Arne Astrup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharma AS
Original Assignee
Nycomed Danmark AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark AS filed Critical Nycomed Danmark AS
Publication of DE69010336D1 publication Critical patent/DE69010336D1/de
Application granted granted Critical
Publication of DE69010336T2 publication Critical patent/DE69010336T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69010336T 1989-07-07 1990-04-20 Pharmazeutische zusammensetzung zum abnehmen. Expired - Fee Related DE69010336T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK339289A DK339289D0 (da) 1989-07-07 1989-07-07 Farmaceutisk praeparat
PCT/DK1990/000106 WO1991000730A1 (en) 1989-07-07 1990-04-20 A slimming pharmaceutical composition

Publications (2)

Publication Number Publication Date
DE69010336D1 true DE69010336D1 (de) 1994-08-04
DE69010336T2 DE69010336T2 (de) 1994-11-03

Family

ID=8122369

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69010336T Expired - Fee Related DE69010336T2 (de) 1989-07-07 1990-04-20 Pharmazeutische zusammensetzung zum abnehmen.

Country Status (19)

Country Link
US (1) US5422352A (de)
EP (1) EP0480934B1 (de)
JP (1) JP2584899B2 (de)
KR (1) KR0159045B1 (de)
AT (1) ATE107858T1 (de)
AU (1) AU638992B2 (de)
CA (1) CA2063598C (de)
DE (1) DE69010336T2 (de)
DK (2) DK339289D0 (de)
ES (1) ES2055911T3 (de)
FI (1) FI920026A0 (de)
HK (1) HK1001821A1 (de)
HU (1) HU220071B (de)
LT (1) LT3536B (de)
LV (1) LV10192B (de)
NO (1) NO920051L (de)
RU (1) RU2109511C1 (de)
UA (1) UA27779C2 (de)
WO (1) WO1991000730A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5865869A (en) * 1991-08-02 1999-02-02 Ecologel Usa, Inc. Solution for plant root watering
WO1994000432A1 (en) * 1992-06-30 1994-01-06 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anorectic epinephrine derivatives
JPH08509203A (ja) * 1992-10-15 1996-10-01 ダナ−ファーバー キャンサー インステテュート インコーポレイテッド ＴＮＦ−α作用の拮抗剤を用いる肥満関連糖尿病▲ＩＩ▼型のインスリン耐性の治療
ES2094687B1 (es) * 1994-08-02 1997-12-16 S A L V A T Lab Sa Combinacion farmaceutica contra la obesidad o el sobrepeso.
FR2746644A1 (fr) * 1996-03-18 1997-10-03 Firion Jackie Produit parapharmaceutique moderateur d'appetit
EP0885008B1 (de) * 1996-09-30 2009-12-30 Dennis Jones Regulation von Körpergewicht durch Materialien basierend auf Zitrusvariationen
US6224873B1 (en) 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
ATE320796T1 (de) * 1996-12-23 2006-04-15 Sla Pharma Ag Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US7232830B2 (en) 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
CA2336004C (en) * 1998-06-26 2006-10-24 Elaine A. Delack Use of histamine h2 agonists for the treatment of multiple sclerosis
US6340482B1 (en) * 2000-05-18 2002-01-22 Zhishin, Llc Methods for inducing weight loss in a human with materials derived from Citrus varieties
US6113949A (en) * 1998-10-27 2000-09-05 Prolab Nutrition, Inc. Weight control product and method of treating hyperlipidemia and increasing vigor with said product
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US6576272B1 (en) * 1999-03-05 2003-06-10 Twin Laboratories Incorporated Dietary supplement and method of using same
WO2001005356A2 (en) * 1999-07-20 2001-01-25 Natrol, Inc. Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant
CA2382666A1 (en) * 1999-08-23 2001-03-01 The Administrators Of The Tulane Educational Fund Modulation of the blood-brain barrier transporter for leptin
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
DE10011541A1 (de) * 2000-03-06 2001-09-20 Reimann Hartmut Verwendung einer Kombination aus Ephedrin und Coffein und/oder Theophyllin zur Vitalisierung von Knochenfischen, Wasserzusatz zur Vitalisierung von Knochenfischen
US6316499B1 (en) 2000-05-18 2001-11-13 Zhishin, Llc Methods for increasing the muscle mass of a human with materials derived from citrus varieties
CN1406131A (zh) * 2000-12-25 2003-03-26 株式会社资生堂 活化交感神经的香料组合物
US7048941B2 (en) * 2001-03-30 2006-05-23 New World Enterprizes, Inc. Chocolate composition as delivery system for nutrients and medications
WO2003022239A2 (en) * 2001-09-07 2003-03-20 Western Holdings Llc Stable water in oil aminophylline emulsions
GB0130763D0 (en) 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
WO2003088953A2 (en) * 2002-04-19 2003-10-30 N.V. Nutricia Multiphasic diet
US8142810B2 (en) * 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
US20040224031A1 (en) * 2003-05-06 2004-11-11 Antonio Zorzano Olarte Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus
WO2005034650A1 (en) 2003-10-17 2005-04-21 Diet Formulations Ltd. Weight-loss supplement
EP1684593A4 (de) * 2003-11-20 2010-02-10 Alteragon Pty Ltd Verfahren zur verringerung von fettablagerungen sowie des körpergewichts bei säugetieren und vögeln
CA2455248A1 (en) * 2004-01-29 2005-07-29 Alexander Zolotoy Oral administration of r-albuterol against obesity
US7524064B2 (en) * 2004-03-09 2009-04-28 Research Foundation Of The State University Of New York Apparatus and method for assessing retinal damage
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20060134230A1 (en) * 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US20060204599A1 (en) * 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
WO2012092056A1 (en) * 2010-12-29 2012-07-05 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with targeted substance delivery
CN104703482A (zh) * 2012-10-08 2015-06-10 利维拉（澳大利亚）有限公司 包含莱克多巴胺和咖啡因的动物饲料补充剂
US9877434B2 (en) 2013-05-30 2018-01-30 Ecologel Solutions, Llc Granular compositions and methods for drought mitigation
BR112016022039A2 (pt) * 2014-03-26 2017-08-15 Rivalea Australia Pty Ltd Método para aprimorar eficácia de alimentação em ruminantes
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
CA2975217C (en) 2015-02-13 2023-08-15 Mars, Incorporated Pet food feeding system
US20180055848A1 (en) * 2015-04-14 2018-03-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Combination of Albuterol and Caffeine as Synergistic Treatment for Obesity or Sarcopenia
GB201522296D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat
WO2020232424A1 (en) 2019-05-16 2020-11-19 Nexus Pharmaceuticals, Inc. Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390164A1 (fr) * 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
DE2743702A1 (de) 1977-06-03 1978-12-14 Pharmaceutical Export Promotio Abmagerungs- oder schlankmacher- zubereitung und verfahren zu ihrer herstellung
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5011843A (en) * 1988-05-31 1991-04-30 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors

Also Published As

Publication number Publication date
AU638992B2 (en) 1993-07-15
WO1991000730A1 (en) 1991-01-24
HK1001821A1 (en) 1998-07-10
RU2109511C1 (ru) 1998-04-27
DK0480934T3 (da) 1994-11-07
LTIP702A (en) 1995-01-31
JPH04507091A (ja) 1992-12-10
EP0480934A1 (de) 1992-04-22
UA27779C2 (uk) 2000-10-16
AU5630890A (en) 1991-02-06
CA2063598A1 (en) 1991-01-08
NO920051D0 (no) 1992-01-03
ATE107858T1 (de) 1994-07-15
CA2063598C (en) 1997-12-09
JP2584899B2 (ja) 1997-02-26
NO920051L (no) 1992-01-31
EP0480934B1 (de) 1994-06-29
ES2055911T3 (es) 1994-09-01
US5422352A (en) 1995-06-06
HUT62798A (en) 1993-06-28
HU9200051D0 (en) 1992-06-29
KR0159045B1 (ko) 1998-12-01
LV10192A (lv) 1994-10-20
LV10192B (en) 1995-06-20
DK339289D0 (da) 1989-07-07
LT3536B (en) 1995-11-27
HU220071B (hu) 2001-10-28
DE69010336T2 (de) 1994-11-03
FI920026A0 (fi) 1992-01-03

Similar Documents

Publication Publication Date Title
ATE107858T1 (de) Pharmazeutische zusammensetzung zum abnehmen.
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
PT977564E (pt) Forscolina para promocao da massa corporal magra
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
DE69637050D1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
SE8802569D0 (sv) Improvements in or relation to somatostatins
EP0214254A1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ES2176495T3 (es) Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida.
IL126175A (en) Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists
IL101675A0 (en) Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
GB2004183A (en) Compositions containing caffeine and ephedrine or their derivatives
KR900017599A (ko) 종양 치료용 약학 조성물
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
ES2053834T3 (es) Un metodo para la preparacion de una sustancia terapeutica.
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
IT1200350B (it) Supporto a pedana per il corpo umano nella pratica dell'idromassaggio adattabile al fondo
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
IT1317079B1 (it) Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee